SIHUAN PHARM (00460) spent 15.189 million Hong Kong dollars on repurchasing 10 million shares on October 15th.
Sihuan Pharmaceuticals (00460) announced that the company invested 151.89 million Hong Kong dollars on October 15, 2025...
SIHUAN PHARM (00460) announced that the company repurchased 10 million shares for HK$15.189 million on October 15, 2025, with a repurchase price of HK$1.5-1.54 per share.
Related Articles
Hunan Silver (002716.SZ) director Rongqi resigns
Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.
China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.
Hunan Silver (002716.SZ) director Rongqi resigns
Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.
China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
